240
Participants
Start Date
June 4, 2023
Primary Completion Date
November 18, 2023
Study Completion Date
December 24, 2023
Y-3 Injection/Y-3 blank injection
The first dose should be completed as soon as possible after randomization; The time from the second dose to the first dose shall not be less than 12h, but not more than 24h+1h; The time interval of each subsequent administration is 24h±1h;
Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing
Chinese People's Liberation Army Northern Theater Command General Hospital, Shenyang
Shenyang First People's Hospital, Shenyang
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou
Beipiao Central Hospital, Beipiao
Daqing Oilfield General Hospital, Daqing
Daqing People's Hospital, Daqing
Xuzhou Central Hospital (Old Hospital Area), Xuzhou
Xuzhou Central Hospital（New compound）, Xuzhou
Xuzhou First People's Hospital, Xuzhou
Lianyungang First People's Hospital, Lianyungang
Lianyungang Second People's Hospital, Lianyungang
Huai 'an First People's Hospital, Huai'an
Taizhou Second People's Hospital, Taizhou
Shandong Third Hospital, Jinan
Liaocheng People's Hospital, Liaocheng
Tancheng County First People's Hospital, Linyi
Tengzhou Central People's Hospital, Tengzhou
Dongyang City People's Hospital, Dongyang
Pingxiang People's Hospital, Pingxiang
Hunan Provincial People's Hospital, Changsha
Nanyang Second People's Hospital, Nanyang
Nanyang South Stone Hospital, Nanyang
The First Affiliated Hospital of Nanyang Medical College, Nanyang
Liuzhou Workers Hospital, Liuzhou
Cangzhou Central Hospital, Cangzhou
Harrison International Peace Hospital, Hengshui
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou
Inner Mongolia Baotou Steel Hospital, Baotou
Inner Mongolia International Mongolian Medicine Hospital, Hohhot
Collaborators (1)
Neurodawn Pharmaceutical Co., Ltd.
INDUSTRY
Beijing Tiantan Hospital
OTHER